See also this year's filing and all EDGAR filings for this company.
PDF Report 0001274792_2015_Merrimack_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001274792, Merrimack Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 132,096,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 5,130,000 |
| 2 | PropertyPlantAndEquipmentNet | 14,502,000 |
| 3 | remainder_Assets | 6,928,000 |
| 4 | LiabilitiesCurrent | 111,142,000 |
| 5 | LiabilitiesNoncurrent | 106,806,000 |
| 6 | remainder_Liabilities | 42,779,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 30,517,000 |
| 9 | ResearchAndDevelopmentExpense | 138,495,000 |
| 10 | remainder_Expenses | 18,230,000 |
| 11 | remainder_Revenues | 102,756,000 |
| 12 | remainder_NetIncome | 927,000 |
| 13 | remainder_ComprehensiveNetIncome | 218,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 158,656,000 |
| 1 | Liabilities | 260,727,000 |
| 2 | Expenses | 187,242,000 |
| 3 | Revenues | 102,756,000 |
| 4 | StockholdersEquity | -102,071,000 |
| 5 | NetIncome | -83,559,000 |
| 6 | ComprehensiveNetIncome | -83,450,000 |
| 7 | BaseVar | 355,263,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -1.46 |
| 9 | EconomicCapitalRatio | 1.19 |
Edgar->Model Mapping
Feature Distribution
Change over Time
